Currently Viewing the "Archives: Resources" archive
Posted January 14, 2022
Upcoming Webinar Series: Expand your HIV Toolkit with CA Statewide Trainings on Extended-Release Injectable Suspensions for HIV Treatment and Prevention (Starting January 20, 2022)
Purpose The purpose of this four-part series is to equip California clinicians, pharmacists, and members of the healthcare team with an in-depth understanding of Cabotegravir/ Rilpivirine, the first FDA-approved long-acting injectable for patients with HIV….
Posted January 14, 2022
Upcoming Summit: The Intersections of Medical Mis/Distrust and its Impact on Transgender Health, HIV Care & Prevention (March 1-2, 2022)
Save the date from March 1 – 2, 10 AM – 2 PM PST for upcoming Summit “See All of Me: The Intersections of Medical Mis/Distrust and its Impact on Transgender Health, HIV Care &…
Posted January 7, 2022
Upcoming: CAPS Methods Core Town Hall (January 11, 2022)
CAPS Town Hall & CAPS Methods Core present: Understanding Socio-Structural Drivers of HIV Transmission Using Epidemiology and Systems Science Anna Hotton, PhD Tues., Jan. 11th, 2022 11:00am – 12:30pm Register Here Interventions to optimally increase…
Posted January 7, 2022
New On-Demand Resource: Aging with HIV Roundtable Discussion
Aging with HIV Roundtable: An On-Demand Resource from Pozitively Aging Although older people with HIV show higher rates of service engagement compared with their younger counterparts, the medical successes that prolong “physical” health can undermine other…
Posted January 7, 2022
New On-Demand Webinar: PrEP for All Ages
PrEP for All Ages Webinar: Engaging Primary Care Providers in Integrating PrEP in Practice Description: Primary care providers (PCPs) have long been a source of reliable health information and care to individuals of all ages….
Posted January 6, 2022
Upcoming: Virtual Transgender Health Training Series (Apply by January 14, 2022)
Join the Pacific AIDS Education & Training Center – Bay Area, North & Central Coast (BANCC) for a 10-week series on transgender health. BANCC envisions a smaller group of participants to create a more intimate…
Posted January 4, 2022
Updates to Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the U.S.
What’s New in the Guidelines? The Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission updated the following sections of the Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce…
Posted December 30, 2021
Upcoming Webinar Series: Expand your HIV Toolkit with CA Statewide Trainings on Extended-Release Injectable Suspensions for HIV Treatment and Prevention (January 20, 2022)
Purpose The purpose of this four-part series is to equip California clinicians, pharmacists, and members of the healthcare team with an in-depth understanding of Cabotegravir/ Rilpivirine, the first FDA-approved long-acting injectable for patients with HIV….
Posted December 29, 2021
Final Webinar: NAHEWD’s Bridging HIV, HCV, & SUD: Innovations in the Field (January 14, 2022)
Overview The final session in NAHEWD’s Bridging HIV, HCV, & SUD: Innovations in the Field 7-part webinar series, Initiation of Medications for Opioid Use Disorder, will be on Friday, January 14th, at 12 pm ET….
Posted December 28, 2021
New: FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention
Drug Given Every Two Months Rather Than Daily Pill is Important Tool in Effort to End the HIV Epidemic On December 21st, 2021, the U.S. Food and Drug Administration approved Apretude (cabotegravir extended-release injectablesuspension) for…
